Member Info for Theanalyzer

TwoGoodToDie

Pleased to see you have now admitted that I am right and that IFRS 15 is the relevant standard and not IFRS 9 as you stating earlier.

Also glad to see you have identified the tests that a Supply client must meet to achieve a True Sale.

On point 1 what are the stock customer constraints on not receiving the product. Simple the stock company has no use for products, no warehouse and unless Supply’s customer goes into liquidation it never takes possession. In a liquidation event the plan is for the stock company to resell the product. The supply company simply has no use for the product.

On point 3 Supply states in numerous presentations that under their True Sale its inventory monetisation clients are free to sell the product to their own customers at which point they buy the stock back.

Thus Supply’s True Sale doesn’t work on these two grounds. It makes no difference if it’s an SPV or a stock company.

TwoGoodToDie

The IFRS standard that is relevant to client companies isn’t IFRS 9 Financial Instruments because the issue is can the client companies recognise the sale of their stock under IFRS 15 revenue recognition. TwoGoodToDie you’re as usual simply wrong, yet again.

Spoiler alert I don’t think the Supply transaction as described by them meet the requirements to be considered a sale under the bill and hold provision of IFRS15 which require the selling company to hold the stock for Supply stock companies only and not market it to their existing customers. The reason for holding is supposed to be a substantive reason not just to effect an artificial sale. The FRC considered that the True Sale didn’t work either.

Over excited ramper pumps stock

Ignores fact that company says it only has enough cash to last until August unless it’s gets delayed strategic investment from China, sells Total Carbide subsidiary or raises more cash or sells parts of business.

TwoGoodToDie

You keep talking about 1/3 rd baby shelf rule which as I have explained to you only applies to S3 filings but not to S1 filings.

S1 filings are more burdensome but don’t have the same restrictions.

On your interpretation how will Nuburu issue the required shares to buy Tekne, fund SYME and pay its historic creditors?

You also ignore the fact that $100 million of shares can now be sold at up to a 30% discount to market price.

Nuburu just filed updated S1 reflecting restated Q1 numbers.

Typically the SEC take 10 days to review amended S1 filings so Nuburu might soon be able to start selling 20 million shares to Yorkville and then it can pay SYME the cash it owes Supply.

TwoGoodToDie

I agree that the Golden Power and S1 approval are government related but the accounting error which delayed the S1 approval process was down to AZ. They also had to amend the other S1 filing because they omitted the lawyers letter.

Who knows if similar errors have been made in supplying information for the Golden Power approvals delaying the process.

Nuburu Doesn’t have the cash

TwoGoodToDie

You do come out with some complete and utter nonsense..

The reason for the delay is the S1 for Yorkville has not yet been declared effective as AZ explains which means Nuburu does have the cash.

It has nothing to do with the Golden Power approval.

Nuburu which has no cash can’t pay Supply which has no cash because AZ who is the CFO for Nuburu messed up Q1 Nuburu financials.

Shawn Taylor, the Chair of the Nuburu Audit Committee, failed to detect and prevent this error. He is also the CFO of Eight Capital Partners whose shares are suspended because he couldn’t get audit completed by 30 June 2025 for a 31 December 2024 year end.

What a shambolic state of affairs.

Dr Jan

Good luck in your future investments.

Dr Jan

TW says you have sold out?

Is that t4ue?

TwoGoodToDie

Despite me raising going concern issue re net liabilities and fund ongoing losses for future 12 months which far exceed the Nuburu funding facility meaning that there is material uncertainty over going concern you still seem unable to understand or accept the simple point that at some stage both Supply and Nuburu need to raise cash to pay off legacy creditors.

Even AZ admits need to pay off historic creditors including preference share date in news release post AGM.

What is the weather like on your planet?

Lucky Bob

Perhaps cash will arrive later today.

Even if Supply gets all the promised Nuburu cash it will still need promise of more funding due to size of deficit in balance sheet when it looks forward 12 months from date of approval of accounts.

Strong results, may well hit EBIDTA profit in second half if revenue growth rates and gross margins are maintained.

Pleasing that they beat internal budget.

TwoGoodToDie

You mean the $100 million S3 filing dated 9 May 2025 which is still subject to completion? Looks like Nuburu were unaware of the 1/3rd rule when they filed the S3 if only they had reached out to an expert like you.

You have ignored all the recent convertible loans issued for cash now being registered under a S1 for 44 million shares which doesn’t have the 1/3 rd restrictions applied to a S3 or baby shelf filing and whilst some have holding periods, other don’t and the lock up periods for some of them are 180 days and the S1 for 20 million shares to be registered issued under the Yorkville SEPA.

Even if shares are not sold immediately they do dilute other shareholders.

As usual you are wrong in your analysis and understanding.

In its Press Release Nuburu indicate that with the approval of financing proposal to issue up to $100 million of shares in non public offerings of up to at 30% discount it now has a mechanism to pay off its preference share liability plus other vendors liabilities.

I wonder how Nuburu’s share price will respond to such dilutive share issues?

I suspect after issue Nuburu will issue an S1 to enable registration of shares so holders can then sell the shares just like it has done with S1 for 47 million shares to various convertible loan note providers

You can’t do a share consolidation without a GM and a Circular which needs a minimum of 21 days notice.

So VRS are running out of time of that option.

Based on their estimates they have about 3 weeks cash left.

Happy

I own both Phoenix and Chesnara in Life sector

Aviva as a composite

All three have high dividend yields

Beasley in non life pumped out very strong numbers last year

Your rights are guaranteed

Unlike a placing it can’t be oversubscribed and it’s fully underwritten it can’t be undersubscribed either.

Littlegiddings

Phoenix , A FTSE 100 was also a life company consolidator but on a much larger scale withover £300 billion of assets.

When it purchased Standard Life it also got a business to sell to new customers.

The HSBC business offers Chesnara the opportunity to do the same.

It means as you say the rate of shrinkage of assets on balance sheet may decline or even reverse